- Avid biological services (NASDAQ:CDMO) is scheduled to announce first-quarter earnings results on Monday, September 9, after the market closes.
- The consensus EPS estimate is -$0.04 (-33.3% YoY) and the consensus revenue estimate is $40.82 million (+8.3% YoY).
- Over the past 2 years, CDMO has beaten EPS estimates 25% of the time and revenue estimates 75% of the time.